Marcus Hacker

Univ. Prof. Dr. med., Full Professor for Nuclear Medicine and Director

Medical University of Vienna

Austria

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Medical Imaging

100%

Radiology

70%

Pet Imaging

100%

In Vivo Imaging

50%

Cancer Biology

50%

Preclinical Imaging

40%

Prostate Cancer

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles20

Assessment of PSMA Expression of Healthy Organs in Different Stages of Prostate Cancer Using [68Ga]Ga-PSMA-11-PET Examinations

Article Link

Year:

2024

The Role of [18F]F-DOPA PET/CT in Diagnostic and Prognostic Assessment of Medullary Thyroid Cancer: A 15-Year Experience with 109 Patients

Article Link

Year:

2024

Characterization of a Syngeneic Orthotopic Model of Cholangiocarcinoma by [18F]FDG-PET/MRI

Article Link

Year:

2024

A PET/MRI study on the effect of obesity and NAFLD on hepatic [18F]FDG uptake.

Article Link

Year:

2024

Comparison of discovery rates and prognostic utility of [68Ga]Ga-PSMA-11 PET/CT and circulating tumor DNA in prostate cancer-a cross-sectional study.

Article Link

Year:

2024

In vivo assessment of safety, biodistribution, and radiation dosimetry of the [18F]Me4FDG PET-radiotracer in adults.

Article Link

Year:

2024

St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrier.

Article Link

Year:

2024

Synaptic signaling modeled by functional connectivity predicts metabolic demands of the human brain.

Article Link

Year:

2024

Advancing 6-bromo-7-[11C]methylpurine to clinical use: improved regioselective radiosynthesis, non-clinical toxicity data and human dosimetry estimates.

Article Link

Year:

2024

Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre, cross-tracer development and validation study.

Article Link

Year:

2024

On the Road towards Small-Molecule Programmed Cell Death 1 Ligand 1 Positron Emission Tomography Tracers: A Ligand-Based Drug Design Approach

Article Link

Year:

2023

Direct Patlak Reconstruction of [68Ga]Ga-PSMA PET for the Evaluation of Primary Prostate Cancer Prior Total Prostatectomy: Results of a Pilot Study

Article Link

Year:

2023

Comparison of Radiation Response between 2D and 3D Cell Culture Models of Different Human Cancer Cell Lines

Article Link

Year:

2023

Dual-Tracer PET-MRI-Derived Imaging Biomarkers for Prediction of Clinically Significant Prostate Cancer

Article Link

Year:

2023

Diagnostic Value of 2-[18F]FDG PET/CT in a Patient with Atypical Subacute Thyroiditis: A Case Report

Article Link

Year:

2022

Evaluation of the Efficacy of a Combined Treatment Using the mTOR-Inhibitor Everolimus and [177Lu]Lu-DOTA-TATE in Nude CD1 Mice with SSTR-Expressing Pancreatic AR42J Xenograft Tumors

Article Link

Year:

2022

CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [68Ga]Ga-Pentixafor in CRC Imaging

Article Link

Year:

2022

Nuclear Molecular Imaging of Disease Burden and Response to Treatment for Cardiac Amyloidosis

Article Link

Year:

2022

A Simultaneous Multiparametric 18F-FDG PET/MRI Radiomics Model for the Diagnosis of Triple Negative Breast Cancer

Article Link

Year:

2022

Imaging Inflammation in Atherosclerosis with CXCR4-Directed [68Ga]PentixaFor PET/MRI—Compared with [18F]FDG PET/MRI

Article Link

Year:

2022

Collaborators19

Markus Mitterhauser

Medical University of Vienna

AUSTRIA

Katja Pinker

Medical University of Vienna

AUSTRIA

Shuren LI

Ao. Univ.-Prof. Dr.

Medical University of Vienna

AUSTRIA

Katharina Pallitsch

AUSTRIA

Alexander Haug

Deputy Head

Medical University of Vienna

AUSTRIA

Barbara Lieder

Professor for Biomolecular and Physiological Chemistry

Universität Wien

AUSTRIA

Katja Steiger

Ludwig-Maximilians-Universität München

GERMANY

Verena Pichler

Universität Wien

AUSTRIA

Dietmar Georg

Head, Division Medical Radiation Physics, Full Professor

Medical University of Vienna

AUSTRIA

Karsten Bamminger

Medical University of Vienna

AUSTRIA

Cecile Philippe

Medical University of Vienna

AUSTRIA

Gerda Egger

Professor

Medical University of Vienna

AUSTRIA

Marius Mayerhoefer

Professor

Weill Cornell Medicine

UNITED STATES

Xiang Li

Professor

Medical University of Vienna

AUSTRIA

Claudia Kuntner

Assistant Professor

Medical University of Vienna

AUSTRIA

Sazan Rasul

Medical University of Vienna

AUSTRIA

Rupert Lanzenberger

Prof. P.D. M.D.

Medical University of Vienna

AUSTRIA

Ivo Rausch

Medical University of Vienna

AUSTRIA

Pascal A. T. Baltzer

AUSTRIA

How do I reach out?

Meet Kite AI

Marcus Hacker

Univ. Prof. Dr. med., Full Professor for Nuclear Medicine and Director

How do I reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Articles20

Assessment of PSMA Expression of Healthy Organs in Different Stages of Prostate Cancer Using [68Ga]Ga-PSMA-11-PET Examinations

The Role of [18F]F-DOPA PET/CT in Diagnostic and Prognostic Assessment of Medullary Thyroid Cancer: A 15-Year Experience with 109 Patients

Characterization of a Syngeneic Orthotopic Model of Cholangiocarcinoma by [<sup>18</sup>F]FDG-PET/MRI

A PET/MRI study on the effect of obesity and NAFLD on hepatic [<sup>18</sup>F]FDG uptake.

Comparison of discovery rates and prognostic utility of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT and circulating tumor DNA in prostate cancer-a cross-sectional study.

In vivo assessment of safety, biodistribution, and radiation dosimetry of the [<sup>18</sup>F]Me4FDG PET-radiotracer in adults.

St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrier.

Synaptic signaling modeled by functional connectivity predicts metabolic demands of the human brain.

Advancing 6-bromo-7-[<sup>11</sup>C]methylpurine to clinical use: improved regioselective radiosynthesis, non-clinical toxicity data and human dosimetry estimates.

Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre, cross-tracer development and validation study.

On the Road towards Small-Molecule Programmed Cell Death 1 Ligand 1 Positron Emission Tomography Tracers: A Ligand-Based Drug Design Approach

Direct Patlak Reconstruction of [<sup>68</sup>Ga]Ga-PSMA PET for the Evaluation of Primary Prostate Cancer Prior Total Prostatectomy: Results of a Pilot Study

Comparison of Radiation Response between 2D and 3D Cell Culture Models of Different Human Cancer Cell Lines

Dual-Tracer PET-MRI-Derived Imaging Biomarkers for Prediction of Clinically Significant Prostate Cancer

Diagnostic Value of 2-[<sup>18</sup>F]FDG PET/CT in a Patient with Atypical Subacute Thyroiditis: A Case Report

Evaluation of the Efficacy of a Combined Treatment Using the mTOR-Inhibitor Everolimus and [177Lu]Lu-DOTA-TATE in Nude CD1 Mice with SSTR-Expressing Pancreatic AR42J Xenograft Tumors

CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [<sup>68</sup>Ga]Ga-Pentixafor in CRC Imaging

Nuclear Molecular Imaging of Disease Burden and Response to Treatment for Cardiac Amyloidosis

A Simultaneous Multiparametric <sup>18</sup>F-FDG PET/MRI Radiomics Model for the Diagnosis of Triple Negative Breast Cancer

Imaging Inflammation in Atherosclerosis with CXCR4-Directed [<sup>68</sup>Ga]PentixaFor PET/MRI—Compared with [<sup>18</sup>F]FDG PET/MRI

Collaborators19

Markus Mitterhauser

Katja Pinker

Shuren LI

Katharina Pallitsch

Alexander Haug

Barbara Lieder

Katja Steiger

Verena Pichler

Dietmar Georg

Karsten Bamminger

Cecile Philippe

Gerda Egger

Marius Mayerhoefer

Xiang Li

Claudia Kuntner

Sazan Rasul

Rupert Lanzenberger

Ivo Rausch

Pascal A. T. Baltzer

How do I reach out?